Remote Programming of Cardiac Implantable Electronic Device

Not Applicable

Completed

• Conditions: Algorithms; Defibrillators, Implantable; Telemedicine; Follow-Up Studies; Pacemaker, Artificial
• Interventions: Other: Interrogation/programming

• Registration Number: NCT05366660
• Lead Sponsor: University Hospital, Bordeaux

Brief Summary

Cardiac Implantable Electronic Devices (CIEDs) such as pacemakers and implantable cardioverter defibrillators, need to be regularly interrogated and reprogrammed to ensure proper functioning. While remote monitoring allows for partial interrogation at a remote location, full interrogation and changing the CIED parameters is only possible when the patient visits a cardiologist capable of performing device programming. This can be challenging for patients and may cause unnecessary delays, particularly in settings of limited resources, enforced physical distancing, and quarantines. We aim to investigate the efficacy and safety of remote programming.

Detailed Description

Cardiac Implantable Electronic Devices (CIEDs) such as pacemakers and implantable cardioverter defibrillators, need to be regularly interrogated to guarantee proper functioning. In France, the follow-up of approximately 400 000 patients implanted with a CIED is performed by cardiologists. Remote monitoring allows for interrogation of contemporary CIEDs and has revolutionized the care for implanted patients. Early detection of arrhythmias, lead issues, battery depletion and algorithm side effects decreases both morbidity and mortality of CIED patients which is why today remote monitoring enjoys a class IA recommendation. While remote interrogation is advancing steadily, remote programming is not at all possible today. CIED problems may be quickly solved by changing the parameters but this is only possible when the patient visits a cardiologist capable of performing CIED programming. This can be challenging for patients and may cause unnecessary delays, particularly in settings of limited resources, enforced physical distancing, and quarantines. Remote programming of a CIED offers multiple advantages such as shorter travel distances for the patient, reduced need for presence of specialized cardiologists (in small clinics or diagnostic centers) and the possibility to offer expert support at remote locations or developing countries. At Bordeaux University, we have developed a method which enables remote programming of a CIED. The method requires the patient to be in direct vicinity of a CIED programmer, while the cardiologist specialized in CIED programming can operate the programmer from any remote location. We aim to investigate the efficacy and safety of remote programming by applying our method to implanted patients to perform remote interrogation and programming changes.

Study Timeline

• Study Start: 2021-06-08
• Primary Completion: 2022-04-04
• Study Completion: 2022-04-04
• Study First Submitted: 2022-05-05
• Study First Submitted QC: 2022-05-05
• Study First Posted: 2022-05-09
• Status Verified: 2024-01
• Last Update Submitted: 2024-01-26
• Last Update Posted: 2024-01-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

• Patient of both sexes over the age of 18
• Patients implanted with a cardiac pacemaker or an automatic defibrillator and an indication for device check-up (interrogation ± programming) which may be periodic as part of their follow-up, postoperative, following a remote monitoring alert, pre/post MRI or following symptoms.
• Person beneficiary of social security insurance.
• Informed consent confirmed in writing (at the latest on the day of inclusion and before any examination required by the research).
• Women of procreating age with effective contraception

Exclusion Criteria

• Patients younger than 18 years old
• Patients who are incapable to understand the study design or to give informed consent.
• Pregnant or breastfeeding women
• Persons placed under judicial protection, curatorship, tutorship.
• Subject deprived of liberty on judicial or administrative decision
• Persons participating in another study who are still in their period of exclusion

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
CIED's interrogation/programming	Interrogation/programming	All the patients will be included in this single arm to interrogate/programm their CIED

Primary Outcome Measures

Name	Time	Method
Successful remote interrogation and programming of CIED	18 months	Success rate of remote interrogation and programming of CIED

Secondary Outcome Measures

Name	Time	Method
To assess the user-friendliness of the system (1)	18 months	Time of the procedure (interrogation and programming)
To assess the user-friendliness of the system (2)	18 months	Type of programming modifications done
To assess the user-friendliness of the system (3)	18 months	Time of intallation procedure
To assess the user-friendliness of the system (4)	18 months	Turnaround time of the command

Trial Locations

Locations (1)

Bordeaux University Hospital; 🇫🇷 Pessac, France